Lung cancer/NSCLC driver genes with high alteration rates include BIRC6 (Baculoviral IAP Repeat Containing 6, 30.23%), EGFR (Epidermal Growth Factor Receptor, 30.23%), and TP53 (Tumor Protein P53, 20.93%). This evidence concerns the gene TP53 and non-small cell lung carcinoma.